Paper
0
Evaluation of prognostic scores in HCC patients undergoing 1L immunotherapy with atezolizumab and bevacizumab
Authors
Simon Gairing,Philipp Mildenberger
Jennifer Gile,Fabian Jost‐Brinkmann,Bernhard Scheiner,Catherine Leyh,Sabine Lieb,Friedrich Sinner,Vincent Jörg,Thorben Fruendt,Vera Himmelsbach,Nada Abedin,Cennet Şahin,Katrin Böttcher,Jasmin Schuhbaur,Simon Labuhn,James Korolewicz,Claudia Fulgenzi,Antonio D’Alessio,Valentina Zanuso,Florian Hucke,Natascha Röhlen,Najib Khaled,Eleonora Ramadori,Lukáš Müller,Arndt Weinmann,Roman Kloeckner,Peter Galle,Nguyen Tran,Sudhakar Venkatesh,Andreas Teufel,Matthias Ebert,Enrico Toni,Dirk‐Thomas Waldschmidt,Jens Marquardt,Dominik Bettinger,Markus Peck‐Radosavljevic,Andreas Geier,Florian Reiter,Lorenza Rimassa,David Pinato,Christoph Roderburg,Thomas Ettrich,Michael Bitzer,Veit Scheble,Ursula Ehmer,Marie‐Luise Berres,Fabian Finkelmeier,Maria González-Carmona,Johann Felden,Kornelius Schulze,Marino Venerito,Florian Bömmel,Leonie Jochheim,Matthias Pinter,Raphael Mohr,Sumera Ilyas,Irene Schmidtmann,Friedrich Foerster
+57 authors
,P MildenbergerJournal
Published
Dec 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This PDF hasn't been uploaded yet.
Do not upload any copyrighted content to the site, only open-access content.
or